Search

everythinglearnresearchcommunity

for

Search:↓

The article concludes that dermatologists should prescribe lifestyle drugs carefully and consider mental health treatments for patients with disorders like BDD.

A substance from a specific gel helped to grow hair effectively in mice, suggesting it could potentially be used to treat hair loss in humans.

Stopping adalimumab and starting methotrexate with topical treatments improved the woman's scalp psoriasis and hair regrew.

Oxidative stress increases in early hair loss, and family history plays a role; antioxidants may help future treatments.

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

A baby boy with 13q deletion syndrome had eye cancer, a woman's vision improved after stopping a breast cancer drug, a man developed cataracts from using Propecia, and a rare skin disorder called Lipoid Proteinosis was discussed. Also, a tool called OCT is useful for diagnosing macular diseases.

Early treatment and lifestyle changes are important for managing PCOS in young people to prevent long-term health issues.

Antiviral medication valganciclovir may improve skin and hair in Trichodysplasia Spinulosa patients.

Eyelash alopecia areata often goes undiagnosed and can lead to complete eyelash regrowth, especially in younger patients.

Various treatments exist for hair loss, but more research is needed for better options.

Taking Propecia might lead to the development of cataracts.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Short telomeres contribute to aging and cancer, and while telomerase can delay aging, it may also promote cancer.

Scalp cooling to prevent hair loss from chemotherapy works for some but not all, and studying hair damage markers could improve prevention and treatment.

The document concludes that changes in eyelashes and eyelid skin can indicate various local and systemic diseases.

Finasteride reduces prostate cancer risk but may increase high-grade cancer chances.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Ruxolitinib treatment may cause eyelash growth.

N-acetyl-L-cysteine (NAC) can prevent DNA damage and protect cells from harm.

PRP treatment may promote hair growth and improve hair density in women with AGA, but more research is needed.

Most vitiligo patients in Makkah are young women, often with family history and thyroid issues.

Punctate follicular porokeratosis is a skin condition with specific features seen in hair follicles.

New treatments for skin conditions in children include a preferred drug for birthmark reduction, proactive creams for eczema and vitiligo, a safe psoriasis medication, and special tissues and socks for eczema and fungal infections.

Dr. Vera H. Price's 1979 work emphasizes the importance of accurate diagnosis and personalized treatment for hair loss.

Researchers developed a method to measure drugs in hair follicles and found that both water-loving and fat-loving drugs can be detected after being applied to the skin.

Balancing treatment effectiveness with side effects is crucial for relapsed follicular non-Hodgkin's lymphoma, especially in older patients.

Hair loss can indicate or worsen with systemic diseases, and treating the underlying condition is important.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

Finasteride, often used for hair loss, can potentially cause cataracts.

Hyperadrenocorticism in ferrets is linked to neutering and indoor housing, and is best treated with surgery and a deslorelin implant.